News | November 07, 2025
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
The FW500 is designed to meet the evolving needs of mid-sized diagnostic laboratories
Results demonstrate favorable safety profile and clinically meaningful improvements in patients with non-ischemic heart failure
Tourmaline is now an indirect wholly owned subsidiary of Novartis
The acquisition will follow the planned separation of Avidity’s early-stage precision cardiology programs into a new, independent company
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
Takeda will make an upfront payment of $1.2 billion, which includes a $100 million equity investment in Innovent
Subscribe To Our Newsletter & Stay Updated
